At the news
? BEARISHIMPACT 7/10 CLUSTER filed Mar 31, 2026 at 20:00 ET
Two Apogee Therapeutics insiders, the CFO and CMO, sold a combined $303K in stock within a week of a $350M public offering, suggesting potential insider concern ahead of material dilution. The sales represent informed selling by senior executives just after the company priced its secondary offering above market.
- CFO Jane Henderson sold $76,014 in shares (900 shares at $84.46) on April 1, 2026
- CMO Carl Dambkowski sold $227,468 in shares (2,698 shares at $84.31) on April 1, 2026
- Total open-market insider sales: $303,482
- Sales occurred 7 days after final pricing of a $350M secondary offering (5M shares at $70.00)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access